Aibotics, Inc. (AIBT) stock
AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Aibotics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aibotics's operating income for the twelve months ending Jun 30, 2026 was -$1.73M. For fiscal 2025 it was -$1.84M. The highest annual figure on record is -$14.22K in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.84M | – |
| FY2024 | Dec 31, 2024 | -$1.63M | – |
| FY2023 | Dec 31, 2023 | -$616.72K | – |
| FY2022 | Dec 31, 2022 | -$1.74M | – |
| FY2021 | Dec 31, 2021 | -$4.99M | – |
| FY2020 | Dec 31, 2020 | -$14.22K | – |
| FY2019 | Dec 31, 2019 | -$251.72K | – |
| FY2018 | Dec 31, 2018 | -$186.07K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$413.66K | – |
| Q1 FY2026 | Mar 31, 2026 | -$359.46K | – |
| Q4 FY2025 | Dec 31, 2025 | -$474.27K | – |
| Q3 FY2025 | Sep 30, 2025 | -$480.37K | – |
| Q2 FY2025 | Jun 30, 2025 | -$360.58K | – |
| Q1 FY2025 | Mar 31, 2025 | -$529.46K | – |
| Q4 FY2024 | Dec 31, 2024 | -$497.28K | – |
| Q3 FY2024 | Sep 30, 2024 | -$385.26K | – |
| Q2 FY2024 | Jun 30, 2024 | -$391.41K | – |
| Q1 FY2024 | Mar 31, 2024 | -$360.87K | – |
| Q4 FY2023 | Dec 31, 2023 | -$188.94K | – |
| Q3 FY2023 | Sep 30, 2023 | -$165.42K | – |
| Q2 FY2023 | Jun 30, 2023 | -$117.35K | – |
| Q1 FY2023 | Mar 31, 2023 | -$145.01K | – |
| Q4 FY2022 | Dec 31, 2022 | -$346.64K | – |
| Q3 FY2022 | Sep 30, 2022 | -$106.98K | – |
| Q2 FY2022 | Jun 30, 2022 | -$160.61K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$104.90K | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.70K | – |
| Q4 FY2020 | Dec 31, 2020 | -$159.45K | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.93K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.11K | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | -$251.72K | – |
| Q3 FY2019 | Sep 30, 2019 | -$55.37K | -386.9% |
| Q2 FY2019 | Jun 30, 2019 | -$26.29K | -158.4% |
| Q1 FY2019 | Mar 31, 2019 | -$40.86K | – |
| Q4 FY2018 | Dec 31, 2018 | -$245.74K | – |
| Q3 FY2018 | Sep 30, 2018 | $19.30K | – |
| Q2 FY2018 | Jun 30, 2018 | $45.02K | – |
See a number that looks wrong?